Target Name: MID1IP1
NCBI ID: G58526
Review Report on MID1IP1 Target / Biomarker Content of Review Report on MID1IP1 Target / Biomarker
MID1IP1
Other Name(s): FLJ10386 | MID1 interacting protein 1, transcript variant 1 | Mid1-interacting protein 1 | Spot 14-related protein | G12-like | Gastrulation-specific G12-like protein | Protein STRAIT11499 | STRAIT11499 | MID1 interacting protein 1 (gastrulation specific G12-like) | spot 14-R | MID1 interacting protein 1 | spot 14-related protein | MID1IP1 variant 3 | gastrulation specific G12 homolog | S14R | THRSPL | MIG12 | MID1 interacting G12-like protein | MID1 interacting protein 1 (gastrulation specific G12 homolog (zebrafish)), transcript variant 3 | Mid1-interacting G12-like protein | MID1IP1 variant 1 | Spot 14-R | M1IP1_HUMAN

MID1IP1: A Potential Drug Target and Biomarker for Multiple Diseases

MID1IP1, also known as FLJ10386, is a protein that is expressed in various tissues and cells in the human body. It is a member of the MID1 gene family, which is involved in the regulation of cell signaling pathways. MID1IP1 has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion.

One of the most promising aspects of MID1IP1 is its potential as a drug target. MID1IP1 has been shown to interact with several protein tyrosine kinases, including TKLF1, TKB, and TKTK. These interactions suggest that MID1IP1 may be a useful target for drugs that are designed to modulate these signaling pathways.

In addition to its potential as a drug target, MID1IP1 has also been shown to be a valuable biomarker for several diseases. For example, MID1IP1 has been shown to be overexpressed in several types of cancer, including breast, ovarian, and colorectal cancer. This suggests that MID1IP1 may be a useful biomarker for these diseases, and that targeting MID1IP1 in combination with other therapies may be a promising strategy for improving treatment outcomes.

MID1IP1 is also of interest to researchers who are studying the role of cell signaling pathways in diseases such as Alzheimer's and Parkinson's. These diseases are characterized by the progressive loss of brain cells, and the underlying causes of these conditions are not fully understood. MID1IP1 has been shown to be involved in several of the signaling pathways that are disrupted in these conditions, including the regulation of neurotransmitter release and the regulation of cell growth.

In conclusion, MID1IP1 is a protein that has the potential to be a drug target and a valuable biomarker for several diseases. Further research is needed to fully understand the role of MID1IP1 in these conditions, and to develop effective therapies that can target MID1IP1 to improve treatment outcomes.

Protein Name: MID1 Interacting Protein 1

Functions: Plays a role in the regulation of lipogenesis in liver. Up-regulates ACACA enzyme activity. Required for efficient lipid biosynthesis, including triacylglycerol, diacylglycerol and phospholipid. Involved in stabilization of microtubules (By similarity)

The "MID1IP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MID1IP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MID1IP1-AS1 | MID2 | MIDEAS | MIDEAS-AS1 | MIDN | MIEF1 | MIEF2 | MIEN1 | MIER1 | MIER2 | MIER3 | MIF | MIF-AS1 | MIF4GD | MIGA1 | MIGA2 | MIIP | MILIP | MILR1 | MIMT1 | MINAR1 | MINAR2 | MINCR | MINDY1 | MINDY2 | MINDY2-DT | MINDY3 | MINDY4 | Minichromosome maintenance (MCM) 2-7 helicase complex | MINK1 | MINPP1 | MIOS | MIOX | MIP | MIPEP | MIPEPP3 | MIPOL1 | MIR1-1 | MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237